Evidence

Peptides for weight loss: which ones are FDA-approved

Which peptides are FDA-approved for weight loss, which are not, and what licensed prescription programs offer instead. Status checked 13 Nov 2026.

By Julian Caraulani · Updated November 20, 2026

Only a few peptides are FDA-approved for weight loss, and they are prescription GLP-1 drugs: semaglutide (Wegovy) and tirzepatide (Zepbound). The peptides most programs on this site sell, such as sermorelin, are not approved for it. Compounded drugs are not FDA-approved. Compare the 27 programs we track on our cost page.

Our #1 pick, partner link · 8.7/10
Embody, from $99/mo
Visit Embody from $99/mo

Price checked Nov 19 · Cancel anytime · Medication included · No email needed

What counts as a peptide

A peptide is a short chain of amino acids, the building blocks of proteins. Many medicines are peptides, including insulin. That is why semaglutide and tirzepatide are peptides too, even though people usually call them "GLP-1 drugs."

Search results for "peptides for weight loss" mix three very different groups. One group is approved drugs with large trials. Another is compounded peptides made by pharmacies, which have no approval for weight loss. The third is vials labeled "for research," which no clinician prescribes. This page covers the first two and leaves the third out.

The approved ones

The Wegovy label says the drug is indicated "to reduce excess body weight and maintain weight reduction long term in" adults and children aged 12 and older with obesity (DailyMed, Wegovy, read 13 Nov 2026). It describes the drug as a GLP-1 (glucagon-like peptide-1) receptor agonist. That means it copies a gut hormone that helps control appetite and blood sugar.

The Zepbound label gives a similar use for "adults with obesity or adults with overweight" who also have at least one weight-related health condition (DailyMed, Zepbound, read 13 Nov 2026). Its label calls it a "glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist," which means it acts on two gut hormone signals.

Both labels carry a boxed warning, FDA's strongest, about thyroid tumors seen in preclinical studies. A prescriber decides who should use them. For current prices and programs for these two drugs, our sister site tracks them at pricetrackerglp1.com. This site compares programs for the other peptides.

Our #1 pick, partner link · 8.7/10
Embody, from $99/mo
Visit Embody from $99/mo

Price checked Nov 19 · Cancel anytime · Medication included · No email needed

The peptides that are not approved for weight loss

Peptide Status (checked 13 Nov 2026) Weight loss claim
Semaglutide (Wegovy) FDA-approved Yes, on the label
Tirzepatide (Zepbound) FDA-approved Yes, on the label
Tesamorelin (Egrifta) FDA-approved for one use No: label says it is not for weight loss management
Sermorelin Compoundable; no approved product on sale No approval; see sermorelin for weight loss
Retatrutide Not approved; FDA says it cannot be compounded No: still in trials
BPC-157, TB-500, MOTS-c, Semax, Epitalon, KPV Covered by the HHS interim policy of 28 Oct 2026 No approval for any use
NAD+, glutathione FDA Category 1 list (under evaluation) No approval for any use

Tesamorelin is the clearest example. Its label limits use to excess belly fat in adults with HIV lipodystrophy. It also says the drug "is not indicated for weight loss management as it has a weight neutral effect" (DailyMed, Egrifta WR, read 13 Nov 2026). Read more in our tesamorelin guide.

For sermorelin, a six-week trial in 11 older men found it "did not change weight, body mass index, waist to hip ratio" (Vittone 1997, PubMed 9005976). No trial we found shows fat loss.

Where the six HHS peptides stand

On 28 Oct 2026 HHS announced that it "does not intend to take enforcement action against a State-licensed pharmacy" that compounds with BPC-157, TB-500, MOTS-c, Semax, Epitalon or KPV under set conditions (Federal Register 2026-22192). That is not FDA approval. The policy is interim, so HHS can change it, and it does not bind any state. Compounded drugs are not FDA-approved, and none of the six has an approved weight loss use. Our peptide legal status tracker keeps the dates. We found no new FDA or HHS action when we checked on 13 Nov 2026.

Evidence grades for weight loss

We grade each peptide A to F on human evidence for weight loss, with the same fixed rubric as our best peptide for each goal pages. A means FDA-approved for the goal or at least two randomized trials in people that found a benefit. F means human trials measured it and found no benefit. The full rules are on our methodology page. Grades reviewed 20 Nov 2026.

Peptide Grade What the human evidence shows
Semaglutide (Wegovy) A FDA-approved to reduce excess body weight (DailyMed)
Tirzepatide (Zepbound) A FDA-approved for adults with obesity, or overweight with a weight-related condition (DailyMed)
Retatrutide A Randomized phase 3 trials published in 2026 (Jastreboff, NEJM; TRIUMPH-2, Lancet). Not approved, and FDA says it cannot be compounded
Tesamorelin A FDA-approved to reduce belly fat in adults with HIV lipodystrophy; in its first phase 3 trial, belly fat fell 15.2% on the drug and rose 5.0% on placebo (Falutz 2007). The label says it is weight neutral, so it is not a weight loss drug
Sermorelin F Two small trials in older adults measured body weight and found no change (Vittone 1997; Khorram 1997). Neither was designed as a weight loss trial
MOTS-c D Preclinical studies only; we found no published trial that gave MOTS-c to people

A grade is not advice to use any of these. A licensed prescriber decides what suits you, and we do not publish doses.

Ranked on safety and priceSee every peptide program side by side

Retatrutide and "fat burning" peptides

Retatrutide is an experimental drug from Eli Lilly. FDA says "Retatrutide and cagrilintide cannot be used in compounding under federal law" (FDA). Our retatrutide vs semaglutide guide covers the trial results.

Lists of "best fat burning peptides" usually name peptides with no human weight loss trials behind them. We do not rank them. A product sold as a fat burner without a prescription is not a licensed program's offer.

Where to get peptides online, the licensed way

A licensed program has a clinician review your health history, and a US pharmacy fills the prescription. Look for plain facts: what the monthly price includes, any membership fee, and how billing repeats. We do not cover sellers of research-labeled vials, because no prescriber is involved.

If your goal is weight loss, ask a clinician about approved options first. If you want a growth hormone peptide for another reason, the cheapest tracked sermorelin plan is Idun Rx at $94 a month (12-month plan). Our top-scored program overall is Embody, with a score of 8.7. See every plan on the sermorelin price page and the best programs ranking. Your prescriber sets the form and amount; we do not publish doses.

FAQ

Peptides for weight loss: which ones work?

The ones with FDA-approved weight loss labels are semaglutide (Wegovy) and tirzepatide (Zepbound), both prescription GLP-1 drugs. Sermorelin, BPC-157 and similar peptides have no weight loss approval, and the sermorelin trial we found showed no change in weight.

Are peptides better than GLP-1 drugs?

The approved GLP-1 drugs are peptides, so the question is partly a mix-up. Wegovy and Zepbound carry weight loss labels backed by large trials. Other peptides do not, and no trial we found shows any of them beating these drugs for weight loss.

Can peptide therapy help with weight loss?

Only some peptide drugs carry that use on a label. Programs selling sermorelin or NAD+ describe body composition goals, but no label lists weight loss. A clinician can tell you whether an approved drug fits you and what a program adds.

Where can I buy peptides for weight loss?

Through a licensed prescriber. A clinician reviews your history and a US pharmacy ships the drug. Compare plans on our cost page. We do not list sellers of research-labeled vials.

Are there oral peptides for weight loss?

Wegovy now has a tablet form, according to its label (DailyMed, Wegovy, read 13 Nov 2026). Other oral peptide products sold for weight loss have no approval. Ask a prescriber which form is right.

Are peptides for weight loss safe for women?

Safety depends on the drug and your health, not on sex alone. Approved drugs list pregnancy and other warnings on their labels. Unapproved peptides have less safety data. A clinician should review any peptide before you start.

Bottom line

Two peptide drugs carry weight loss labels. The rest are not approved for it. To price licensed peptide programs, use our cost page or the best peptide programs ranking.

Check this page with an AI assistant:ChatGPTPerplexityClaude

Not affiliated with OpenAI, Perplexity or Anthropic.